SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nitto Denko Avecia to Evaluate EnPlusOne’s ezRNA Platform

A partnership will evaluate EnPlusOne’s ezRNA platform for RNA therapeutics manufacturing, connecting its expanded RNA chemistry and scalable enzymatic synthesis with Avecia.

Related stories